• SENSEX 76,515.43
    362.57 (+0.48%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
  • Gland Pharma
    2,969.85 3,039.00(%)
  • Power Fin.Corpn.
    357.70 486.45(%)
  • IFCI
    107.45 107.45(%)
  • Shriram Finance
    1,036.40 584.25(%)
  • Tata Technolog.
    796.45 507.50(%)
  • ESDS Software
    895.55 895.55(%)
  • Lenskart Solut.
    694.75 694.75(%)
  • Netweb Technol.
    5,170.00 2,514.75(%)
  • Lumino Inds
    122.00 122.00(%)
  • Kesar India
    1,180.00 1,341.00(%)
  • Multi Comm. Exc.
    3,287.00 3,479.80(%)
  • Tejas Networks
    623.90 644.75(%)
  • RBL Bank
    417.00 417.00(%)
  • ICICI AMC
    2,960.00 2,528.90(%)
  • Polycab India
    8,254.00 6,660.50(%)
  • New India Assura
    234.60 234.60(%)
  • Wockhardt
    2,107.95 2,420.00(%)
  • Angel One
    308.20 360.20(%)
  • Jindal Worldwide
    57.06 57.06(%)
  • Lalithaa Jewel
    308.55 308.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Norris Medicines Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3347.0
  • ISIN : INE744C01029
13.65 -1 (-4.48%)
  • As on 05 Sep 2026 (EOD)

  • Today’s Low

    13.63

  • Today’s High

    14.85

  • Open

    14.50

  • Perv Close

    14.29

  • 52W Low

    12.00

  • 52W High

    19.63

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    13.65

  • Div & Yield %

    0.00

  • Book Value(₹)

    -15.07

  • Debt-Equity Ratio

    -4.48

  • AGM Date

    04-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    13.65

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.00

  • BV (₹)

    -15.10

  • Sales( ₹ in Cr.)

    8.13

  • NP (in Cr.)

    -0.28

  • NP Var(%)

    77.0

  • Div%

    0.0

  • CPS (₹)

    0.20

  • EPS (₹)

    -0.30

  • Traded Value (₹ in Lakhs)

    13.65

  • 52 Week High

    19.63

  • 52 Week Low

    12.00

  • Price BSE

    14.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    13.65

  • P/C Ratio

    66.60

  • P/E Ratio

    -49.90

  • Price Vs.BV

    -0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 5.82 5.64 8.36 9.44 12.25 7.90
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.06
Net Sales 5.82 5.64 8.36 9.44 12.25 7.84
Other Income 0.06 0.03 0.01 0.03 0.05 0.09
Stock Adjustments -0.08 0.50 -0.13 -2.04 0.79 0.64
Total Income 5.80 6.17 8.24 7.43 13.09 8.57
EXPENDITURE :            
Raw Materials 3.37 3.16 3.23 3.57 9.53 5.16
Power and Fuel Cost 0.63 0.76 0.90 0.81 0.97 1.22
Employee Cost 1.41 1.82 2.30 2.33 3.10 3.23
Other Manufacturing Expenses 0.17 0.18 0.38 0.28 0.37 0.48
Selling and Administration Expenses 0.38 0.36 0.43 0.39 0.68 0.55
Miscellaneous Expenses 0.04 0.03 0.06 0.09 0.13 0.00
Employee Benefit Expenses 1.41 1.82 2.30 2.33 3.10 3.23
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6.00 6.32 7.30 7.47 14.78 10.63
Operating Profit -0.20 -0.16 0.94 -0.05 -1.70 -2.07
Interest 0.44 0.37 1.50 1.48 1.63 0.88
Gross Profit -0.64 -0.53 -0.56 -1.53 -3.33 -2.95
Depreciation 0.54 0.57 0.63 0.66 0.67 0.73
Profit Before Tax -1.18 -1.10 -1.19 -2.19 -4.00 -3.68
Current Tax 0.00 0.00 0.00 0.00 0.00 -0.84
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.06 0.09 0.56 1.08 0.97 0.00
Reported Net Profit -1.24 -1.19 -1.75 -3.26 -4.96 -2.84
Extraordinary Items 0.00 -0.02 0.00 0.00 0.00 0.00
Adjusted Net Profit -1.24 -1.17 -1.75 -3.26 -4.96 -2.84
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -25.39 -24.20 -22.45 -19.19 -14.23 -11.39
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -26.63 -25.39 -24.20 -22.45 -19.19 -14.23
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.25 -1.20 -1.76 -3.29 -5.00 -2.86
Earnings Per Share(Adj)-Unit Curr -1.25 -1.20 -1.76 - -5.00 -2.86
Book Value -14.98 -13.73 -12.54 -10.77 -7.49 -2.49
Book Value(Adj)-Unit Curr -14.98 -13.73 -12.54 - -7.49 -2.49

Shareholding Pattern

  • Promoter Group

    34.01%

  • Public Share Holding

    65.99%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,000,000 10.00 1,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,401,571 24.01 2,400,071 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,401,571 34.01 3,400,071 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 6,420 0.06 6,420 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 510 0.01 0 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 6,930 0.07 6,420 6
2] Non Institution
Bodies Corporate 4,391,557 43.91 4,360,807 57
Clearing Members 38,946 0.39 38,946 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 39,472 0.39 39,381 52
Foreign Non Institution Other 27,150 0.27 27,150 2
Hindu Undivided Families 17,121 0.17 17,121 57
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 27,480 0.27 27,480 1
Individuals holding nominal share capital up to Rs. 1 lakh 2,050,255 20.50 781,672 25,590
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 90 0.00 90 1
Others 0 0.00 0 0
Sub Total 6,592,199 65.92 5,292,775 25,765
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,000,700 100.00 8,699,266 25,777

Company Background

Norris Medicines LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Norris Medicines Ltd
  • BSE Code : 3347.0
  • ISIN : INE744C01029

  • Incorporation Year

    1990

  • Registered Office

    Plot No 801/P & 802
    GIDC Industrial Estate, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-2646-223462/227530

  • FAX

    91-2646-250126

  • Chairman

    Vimal D Shah

  • Managing Director

    Vimal D Shah

  • Company Secretary

    Priyanka Lohia

  • Auditor

    Bahedia & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Norris Medicines Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Norris Medicines 13.65 5.88 5.82 -36.89 0.00
Abbott India 26,071.95 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,930.80 2,304.07 2,275.58 102.15 27.86
Glaxosmi. Pharma 2,958.60 3,932.76 3,790.20 47.26 58.17
Novartis India 1,637.10 398.23 356.27 41.34 16.64
Cipla 1,385.00 20,102.60 18,979.95 36.40 13.88
Bliss GVS Pharma 668.70 773.53 729.81 62.09 12.51
Amrutanjan Healt 506.25 520.13 502.55 27.12 24.16
Fermenta Biotec. 498.35 474.15 450.25 23.27 18.77
Guj. Themis Bio. 411.75 152.47 150.80 110.09 27.21
Ambalal Sarabhai 43.72 19.52 3.94 80.96 6.77